From Casetext: Smarter Legal Research

Shire Dev., LLC v. Watson Pharm., Inc.

Supreme Court of the United States
Jan 26, 2015
574 U.S. 1134 (2015)

Opinion

No. 14–206.

01-26-2015

SHIRE DEVELOPMENT, LLC, et al., petitioners, v. WATSON PHARMACEUTICALS, INC., et al.


On petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Federal Circuit for further consideration in light of Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., 574 U.S. ––––, 135 S.Ct. 831, ––– L.Ed.2d –––– (2015).


Summaries of

Shire Dev., LLC v. Watson Pharm., Inc.

Supreme Court of the United States
Jan 26, 2015
574 U.S. 1134 (2015)
Case details for

Shire Dev., LLC v. Watson Pharm., Inc.

Case Details

Full title:SHIRE DEVELOPMENT, LLC, et al., petitioners, v. WATSON PHARMACEUTICALS…

Court:Supreme Court of the United States

Date published: Jan 26, 2015

Citations

574 U.S. 1134 (2015)
135 S. Ct. 1174
191 L. Ed. 2d 130
83 U.S.L.W. 3121

Citing Cases

Shire Dev., LLC v. Mylan Pharms., Inc.

In January 2015, the Supreme Court issue its opinion in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., 135…

Shire Dev., LLC v. Mylan Pharms., Inc.

Shortly after the Supreme Court issued Teva, it granted Shire's petition for certiorari in Watson, vacated…